Based on past experience listening to Mark's interviews, I

New Post Public Reply Private Reply Replies (0) Message Board
grow Mrdrifter #39227
367
Based on past experience listening to Mark's interviews, I think this tweet can be read in more than one way, especially in light of SFOR not actually currently being listed on the November arguments calendar. I don't think his speaking or writing is always fully in sync with his thoughts. The grammar gets weird at times. I've noticed this on several occasions.

Here is his tweet again.
https://twitter.com/strikeforcetech/status/10...47200?s=21
"As i always said, we have no call as to when our appeal is discussed but it is currently on the November schedule in the courts, which doesn't mean it will be. Yes, very exciting."

Face value take away;
It's on the schedule but might not be.

That is IMO a really unclear message. It seems a bit like these quotes which a lot of people seem to enjoy.
https://www.brainyquote.com/authors/yogi_berra

An downbeat interpretation;
Can't discuss appeal. The courts have posted the November arguments calendar. We don't know when we will be scheduled. We are excited.

An upbeat interpretation but a big stretch since he doesn't comment on the court;
Can't discuss appeal. It's on the court workload in November. We don't know if it will be scheduled for oral argument. We are excited.

IMO people will read what they want to read in his tweet, but he does clearly say it's exciting which I liked to see. However I still place my expectations for the appeal to now be heard in December at the earliest, and I will be pleasantly surprised if it comes earlier. Yes my expectations are a moving timeline pushed further out with each month of argument calendaring that doesn't have SFOR on it.


I hope at least people find the Yogi Bear quotes entertaining.



Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

8x8, Inc. Achieves Earnings Beat with Strong Future Guidance

Updated Category News Views 91

8x8, Inc. Reports Strong Earnings Amid Growth Initiatives 8x8, Inc. (NASDAQ: EGHT), the prominent cloud communications provider, has experienced a notable uptick of 2% in its share value during after-hours trading following the release of their latest quarterly earnings. The company reported second quarter results that exceeded market expectations, providing a boost in...

Continue Reading
Investors Can Take Action in Indivior PLC Fraud Case Today

Updated Category News Views 73

Investors Encouraged to Join Indivior PLC Securities Fraud Lawsuit The Schall Law Firm, a well-known litigation firm dedicated to protecting shareholders' rights, is reaching out to investors about an important class action lawsuit against Indivior PLC (NASDAQ: INDV). This case concerns potential breaches of the Securities Exchange Act of 1934 and Rule 10b-5 as...

Continue Reading
McDermott Expands Board with New Strategic Leaders

Updated Category News Views 286

McDermott Strengthens Leadership with New Board Appointments McDermott International, Ltd has made a significant strategic move by announcing the addition of two accomplished professionals, Michael Martino and Farhad Nanji, to its Board of Directors. This change is aimed at bolstering the company’s leadership as it navigates the complex landscapes of the energy...

Continue Reading
United Therapeutics Achieves Record Stock Price of $366.23

Updated Category News Views 52

United Therapeutics Reaches New Heights in Stock Value United Therapeutics Corporation (NASDAQ: UTHR) has achieved a remarkable milestone by reaching an all-time high of $366.23. This significant increase signifies a robust period of growth for the biotech company, which has seen its stock jump by an impressive 54.22% over the past year. The surge is largely attributed to...

Continue Reading
DoorDash Surges to New Heights as Growth Strategies Flourish

Updated Category News Views 303

DoorDash Reaches New Stock Heights DoorDash (NASDAQ: DASH) has experienced a remarkable surge, with its stock recently hitting a 52-week high of $181.78. This leap signifies not only a thriving business model but also a considerable increase in investor confidence in the food delivery service. With a market cap of $75.3 billion, DoorDash has shown impressive growth with a...

Continue Reading